Valuation (69%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 17.45 | 22.10 |
PEG Ratio (TTM) | -5.01 | 0.36 |
P/S Ratio (TTM) | 0.77 | 1.21 |
P/B Ratio (TTM) | 1.06 | 4.70 |
P/FCF Ratio (TTM) | 25.51 | 25.08 |
Price to 5YR AVG Earnings Ratio | 19.43 | 19.23 |
Price to 5YR AVG FCF Ratio | 27.39 | 33.35 |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | 4.55% | 6.86% |
ROE (TTM) | 10.70% | 22.93% |
Net Profit Margin (TTM) | 4.45% | 5.57% |
ROIC 5YR AVG | 9.41% | 23.72% |
Growth (72%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 4.16% | 138.04% | 86.67% |
Revenue | -0.21% | 10.66% | 5.14% |
Net Income | 3.14% | 139.35% | 86.18% |
Cash Flow | 3.34% | 28.89% | 14.12% |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.23 | 1.22 |
Quick Ratio (TTM) | 1.19 | 1.20 |
D/E Ratio (TTM) | 0.28 | 0.89 |
Interest Coverage (TTM) | 28.67 | 19.05 |
Piotroski F-Score | 7 | 6 |
Altman Z-Score | 2.61 | 3.73 |
LTL to 5YR AVG FCF | 14.11 | 8.77 |
Shares Outstanding Growth 5YR AVG | -1.08% | -0.77% |